Camurus appoints Jane Buus Laursen as Chief Corporate Development Officer
Lund, Sweden — 17 February 2026 — Camurus (NASDAQ STO: CAMX) today announced that Jane Buus Laursen has been appointed…
78,250€
0,32%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Notable healthcare headlines for the week: AstraZeneca, CVS Health, and Moderna in focus
…
Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory
Shore Capital downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to hold from buy, citing a less favourable earnings trajectory as the drugmaker...…
Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory
Shore Capital downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to hold from buy, citing a less favourable earnings trajectory as the drugmaker...…
Citi maintains buy on AstraZeneca with £170 target, cites sector-best pipeline
Double-digit earnings outlook and strong trial momentum support top pick status AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) remains a top pick at…
Citi maintains buy on AstraZeneca with £170 target, cites sector-best pipeline
Double-digit earnings outlook and strong trial momentum support top pick status AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) remains a top pick at…
AstraZeneca PLC (AZN) Q4 2025 Earnings Call Transcript
…
Heres What Key Metrics Tell Us About Astrazeneca (AZN) Q4 Earnings
The headline numbers for Astrazeneca (AZN) give insight into how the company performed in the quarter ended December 2025, but…
US-UK pharma deal isn’t enough to get AstraZeneca investing in Britain again
LONDON — AstraZeneca CEO Pascal Soriot says the pharmaceutical giant is still not ready to restart its paused U.K. investments,…
AstraZeneca’s growth engine stays on track despite cost pressures
AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) full-year results showed the pharmaceutical group navigating a challenging comparison period with a robust...…
FTSE 100 slips as Standard Chartered and BP weigh
The FTSE 100 slipped on Tuesday as investors digested a raft of corporate updates from companies including Barclays, AstraZeneca, and…
KORREKTUR/ROUNDUP: Astrazeneca will 2026 mehr verdienen - Aktie nahe Rekordhoch
(Es wird in der Überschrift und im 1. Absatz klargestellt, dass die Aktie sich ihrem Rekordhoch genähert rpt genähert hat.)…
ROUNDUP: Astrazeneca will auch 2026 mehr verdienen - Aktie auf Rekordhoch
CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca stellt sich nach einem schwungvollen Jahr auf weiteres Wachstum ein und will zugleich…
BARCLAYS stuft ASTRAZENECA auf Overweight
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Astrazeneca nach Zahlen auf "Overweight" mit einem Kursziel…
JEFFERIES stuft ASTRAZENECA auf Buy
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca nach Zahlen zum vierten Quartal auf "Buy"…
AstraZeneca lifts earnings as pipeline delivery and global expansion underpin growth
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) delivered strong full-year results for 2025, driven by solid commercial performance across all major regions and...…
Drugmaker AstraZeneca forecasts sales and profit growth in 2026
AstraZeneca on Tuesday forecast profit and sales growth in 2026, betting on demand for its cancer and cardiovascular treatments while…
AstraZeneca earnings up next after NYSE debut, China expansion By Investing.com
AstraZeneca earnings up next after NYSE debut, China expansion…
Why AstraZeneca is Investing $15bn in Chinese Manufacturing
AstraZeneca will invest US$15bn in China through 2030 to boost R&D, advanced manufacturing and next generation therapies for patients around…
Spotlight On Coca-Cola, Ford, AstraZeneca Earnings
…